Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
厄洛替尼+贝伐珠单抗的Ⅱ期研究中3个治疗组的疗效和耐受性结果[16]
Efficacy and tolerability outcomes of the 3 treatment arms of the phase Ⅱ study of erlotinib plus bevacizumab[16]
| 疗效/耐受性指标 | 厄洛替尼+贝伐珠单抗 | 贝伐珠单抗+化疗 | 单一化疗 |
| Abbreviations: OS=overall survival; PFS=progression-free survival. Note: Reprinted with permission from the copyright holder ©CIG Media Group, LP 缩写：OS：总生存期；PFS：无进展生存期。 注：本图得到版权所有者©CIG Media Group, LP复制许可 | |||
| 中位OS（月） | 13.7 | 12.6 | 8.6 |
| 1年生存率（%） | 57.4 | 53.8 | 33.1 |
| 6个月PFS率（%） | 33.6 | 30.5 | 21.5 |
| 不良反应导致治疗中止的发生率（%） | 13 | 28 | 24 |
